Gut microbiota-derived SCFAs and MetS-related nephropathy

QR Code

Gut microbiota-derived SCFAs and MetS-related nephropathy

Metabolic syndrome (MetS) is a group of complex disorders characterized by abnormalities in the metabolism of proteins, fats, carbohydrates, and other substances in the human body. The kidney plays a vital role in these metabolic processes. Similarly, metabolic disorders can lead to renal damage, wh...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaofang Tian, Li Sun, Shengjie Guo, Liying Yuan, Tang Zhang, Chengqian Huang, Tingting He, Qianfeng Jiang, Yizhou Zeng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Nutrition
Subjects:	gut microbiota short-chain fatty acids metabolic syndrome chronic kidney disease energy metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fnut.2025.1561271/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting gut microbiota for diabetic nephropathy treatment: probiotics, dietary interventions, and fecal microbiota transplantation
by: Xiaoran Wang, et al.
Published: (2025-06-01)

The role of gut microbiota in insulin resistance: recent progress
by: Hongfang Ji, et al.
Published: (2025-07-01)

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART 2. GUT MICROBIOTA AND OBESITY
by: D. A. Kashtanova, et al.
Published: (2015-10-01)

Interplay between gut microbiota and acute kidney injury: a review of their mutual influence and causation
by: Niroj Mali, et al.
Published: (2025-12-01)

Exploring the influence of gut microbiota metabolites on vitiligo through the gut-skin axis
by: Chuanjian Yuan, et al.
Published: (2025-07-01)

Effectiveness of personalized granola tailored to the gut microbiota for improving gut environment and mood states
by: Hiroyuki Sasaki, et al.
Published: (2025-07-01)

Gut microbiota and cardiovascular risk factors. Part IV. Arterial hypertension, smoking and the gut microbiota
by: D. A. Kashtanova, et al.
Published: (2016-02-01)

Metabolic potential of gut microbiota in helminth infections as a way to achieve bronchial asthma control
by: T. S. Sokolova, et al.
Published: (2023-10-01)

Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01)

Ozone rectal insufflation inhibits the development of atherosclerosis in ApoE−/−mice, which is mediated by the regulation of gut microbiota and metabolites
by: Ruihua Li, et al.
Published: (2025-06-01)

Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development
by: L. E. Vasilyeva, et al.
Published: (2021-11-01)

Disorders of Gut Microbiota and Plasma Metabolic Profiles May Be Associated with Lymph Node Tuberculosis
by: Yun Long, et al.
Published: (2025-06-01)

Gypenosides Alleviate Hyperglycemia by Regulating Gut Microbiota Metabolites and Intestinal Permeability
by: Rong Wang, et al.
Published: (2025-07-01)

Lactobacillus helveticus mitigates diarrhea and inflammation induced by enterotoxigenic E. coli through rebalance of gut microbiota
by: Zhen Zhang, et al.
Published: (2025-01-01)

Rewiring the Brain Through the Gut: Insights into Microbiota–Nervous System Interactions
by: Ilinca Savulescu-Fiedler, et al.
Published: (2025-06-01)

Role of gut microbiota in ischemic stroke: A narrative review of human and animal studies
by: Guangtang Chen, et al.
Published: (2024-06-01)

Insoluble dietary fiber from Chinese cabbage leaves improves glucose and lipid metabolism disorders in HFD-fed mice by mediating gut microbiota
by: Ya-Die Niu, et al.
Published: (2025-08-01)

A synbiotic combination of mixed probiotics and oligofructose restores intestinal microbiota disturbance in DSS-induced colitis in mice
by: Weiwei Ma, et al.
Published: (2025-07-01)

The effect of dietary transition on infant microbiota composition and metabolic activity captured with the simulator of the human intestinal microbial ecosystem (SHIME)
by: Shadi Pakroo, et al.
Published: (2025-01-01)

Modulating the Gut–Muscle Axis: Increasing SCFA-Producing Gut Microbiota Commensals and Decreasing Endotoxin Production to Mitigate Cancer Cachexia
by: Sagnik Roy, et al.
Published: (2025-06-01)

GUT MICROBIOTA AND CARDIOVASCULAR RISK FACTORS. PART III. LIPID PROFILE, CARBOHYDRATE METABOLISM AND GUT MICROBIOTA
by: O. N. Tkacheva, et al.
Published: (2015-12-01)

Association between dietary index for gut microbiota and cardiovascular-kidney-metabolic syndrome: a population-based study
by: Dan Long, et al.
Published: (2025-07-01)

Short-chain fatty acids: key antiviral mediators of gut microbiota
by: Zhiqiang Xu, et al.
Published: (2025-07-01)

Interactions between traditional chinese medicine and gut microbiota in chronic diseases
by: Lei Chen, et al.
Published: (2025-09-01)

Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development
by: O. M. Drapkina, et al.
Published: (2020-05-01)

Dietary and environmental modulation for the gut environment: yogurt promotes microbial diversity while chloride hot springs improve defecation status in healthy adults
by: Jungmi Choi, et al.
Published: (2025-06-01)

Bisphenol F exposure induced vascular toxicity through intestinal microbiota imbalance
by: Jianlong Yan, et al.
Published: (2025-07-01)

Will gut, oral, and vaginal microbiota influence the outcome of FET or be influenced by FET? A pilot study
by: Zhao Zhang, et al.
Published: (2025-07-01)

Gut microbiota and metabolomics in metabolic dysfunction-associated fatty liver disease: interaction, mechanism, and therapeutic value
by: Luyu Wang, et al.
Published: (2025-07-01)

Comprehensive functional profiling of yeasts: gastrointestinal resistance, metabolic capacities, and psychobiotic potential
by: Amir Shazad, et al.
Published: (2025-12-01)

Research progress on immunometabolism and gut microbiota in cryptococcal meningitis: mechanisms and therapeutic implications
by: Sha Wen, et al.
Published: (2025-07-01)

The impact of altered gut microbiota and lipid metabolism on the progression of endometrial cancer in overweight populations
by: Jiayu Chen, et al.
Published: (2025-07-01)

Gut Microbiome Composition Changes During Insomnia Treatment with Lemborexant
by: Miyata S, et al.
Published: (2025-07-01)

Effect of Coffee Extracts with Different Roasting Degrees on Lipid Metabolism and Gut Microbiota in High-Fat Fed Mice
by: WANG Chunhua, XIAO Ying, SUN Bin, PAN Liang, LIU Jieying, JIANG Yongying, ZHOU Yiming, YE Lin, LIU Xiaojie
Published: (2025-07-01)

Schisandrin B alleviates metabolic associated fatty liver disease by regulating the PPARγ signaling pathway and gut microbiota in mice
by: Jiuchen Wan, et al.
Published: (2025-07-01)

Gut microbiota and tuberculosis infection: interaction and therapeutic potential
by: Yinghui Chai, et al.
Published: (2025-12-01)

Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease
by: Emili Bruna Toso Bueno, et al.
Published: (2025-06-01)

The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
by: Jue Zhu, et al.
Published: (2025-07-01)

Melatonin Mitigates Sarcopenic Obesity via Microbiota and Short‐Chain Fatty Acids: Evidence From Epidemiologic and In Vivo Studies
by: Xiaoxing Mo, et al.
Published: (2025-06-01)

Multi-strain probiotics attenuate carbohydrate-lipid metabolic dysregulation in type 2 diabetic rats via gut-liver axis modulation
by: Yecheng Gao, et al.
Published: (2025-07-01)